Low coverage of seasonal influenza vaccination in the elderly in many European countries

Mereckiene, Jolita; Cotter, Suzanne; Weber, J. Todd; Nicoll, A; Lévy-Brühl, Daniel; Ferro, António; Tridente, Giuseppe; Zanoni, Giovanna; Berra, P; Salmaso, Stefania; O’Flanagan, D

doi:10.2807/ese.13.41.19001-en

Cited by 46 publications

(32 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Every year, these persons are invited to collect a free vaccine at the pharmacy and to be vaccinated by their general practitioner. The coverage rate we report, based on exhaustive reimbursement data, is however slightly higher than the coverage rate of 56–68% reported for older adults in previous studies and comparable to those of other Western European countries .…”

Section: Discussioncontrasting

confidence: 60%

Effect of dementia on receipt of influenza vaccine: a cohort study in French older adults using administrative data: 2007–2012

Gallini

Coley

Andrieu

et al. 2017

Fundamemntal Clinical Pharma

View full text Add to dashboard Cite

Despite guidelines stating the vaccine benefit in this population, older adults with dementia may be less likely to receive influenza vaccine than cognitively intact older adults. But no study has yet reported on vaccine uptake in patients newly diagnosed with dementia or whether years since dementia diagnosis influences vaccine uptake. We conducted a cohort study in the French Health Insurance database (Echantillon Généraliste de Bénéficiaires) which contains hospital data and claims for a 1/97th random sample of the French population. Diseased subjects were ≥65 years and had a new record of dementia diagnosis between September 1, 2007, and August 31, 2008. Vaccine receipt was measured via influenza vaccine dispensing in community pharmacies. We described influenza vaccination rates up to 2011-2012 and estimated adjusted relative risks (aRR) for vaccine receipt each year using multivariate modified Poisson models controlling for sociodemographics, comorbidities, and health resources use. Four hundred and seven subjects with dementia (mean age 81.8 years, 69.3% females) and 4862 subjects (mean age 75.2 years, 61.3% females) without dementia were included. In 2008-2009, influenza vaccination prevalence was 70.0% (95% CI = [65.3-74.4]) and 70.2% (95% CI = [68.9-71.4]) in subjects with and without dementia, respectively (aRR = 0.93; 95% CI = [0.87-1.00]). In 2009-2010, the aRR was of the same magnitude (aRR = 0.96, 95% CI = [0.90-1.03]), but in 2010-2011 and 2011-2012, the aRR was 1.02 (95% CI = [0.94-1.11]) and 1.05 (95% CI = [0.96-1.14]), respectively. Subjects with dementia had a slightly nonsignificant lower receipt of influenza vaccine in the year following dementia diagnosis than subjects without dementia. In subsequent years, divergent trends were observed in vaccine uptake according to dementia status.

show abstract

Section: Discussioncontrasting

confidence: 60%

Effect of dementia on receipt of influenza vaccine: a cohort study in French older adults using administrative data: 2007–2012

Gallini

Coley

Andrieu

et al. 2017

Fundamemntal Clinical Pharma

View full text Add to dashboard Cite

show abstract

“…Some countries focussed on vaccinating the vulnerable very young children in particular [4,24]. In the previous seasonal VENICE survey conducted in 2008 only six countries recommended vaccine for children but in the pandemic 19 countries recommended this: 13 as part of the overall population, and six for specific age groups (age groups varied between countries) [13,25,26].…”

Section: Discussionmentioning

confidence: 99%

Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe

Mereckiene

Cotter²,

Weber

et al. 2012

Eurosurveillance

Self Cite

View full text Add to dashboard Cite

show abstract

“…Age group/ Children (months/years) Adults (years) Country identified specific recommendations for different risk groups in each country and obtained vaccination coverage data for the 2006-7 or previous influenza seasons [7,8].…”

Section: Introductionmentioning

confidence: 99%

Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009

Cotter²,

et al. 2010

Self Cite

View full text Add to dashboard Cite

In 2009 the second cross-sectional web-based survey was undertaken by the Vaccine European New Integrated Collaboration Effort (VENICE) project across 27 European Union (EU) member states (MS), Norway and Iceland (n=29) to determine changes in official national seasonal influenza vaccination policies since a survey undertaken in 2008 and to compare the estimates of vaccination coverage between countries using data obtained from both surveys. Of 27 responding countries, all recommended vaccination against seasonal influenza to the older adult population. Six countries recommended vaccination of children aged between six months and <18 years old. Most countries recommended influenza vaccination for those individuals with chronic medical conditions. Recommendations for vaccination of healthcare workers (HCW) in various settings existed in most, but not all countries. Staff in hospitals and long-term care facilities were recommended vaccination in 23 countries, and staff in out-patient clinics in 22 countries. In the 2009 survey, the reported national estimates on vaccine coverage varied by country and risk group, ranging from 1.1% - 82.6% for the older adult population; to between 32.9% -71.7% for clinical risk groups; and from 13.4% -89.4% for HCW. Many countries that recommend the influenza vaccination do not monitor the coverage in risk groups. In 2008 and 2009 most countries recommended influenza vaccination for the main risk groups. Hovewer, despite general consensus and recommendations for vaccination of high risk groups many countries do not achieve high coverage in these groups. The reported vaccination coverage still needs to be improved in order to achieve EU and World Health Organization goals.

show abstract

Low coverage of seasonal influenza vaccination in the elderly in many European countries

Cited by 46 publications

References 3 publications

Effect of dementia on receipt of influenza vaccine: a cohort study in French older adults using administrative data: 2007–2012

Effect of dementia on receipt of influenza vaccine: a cohort study in French older adults using administrative data: 2007–2012

Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe

Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009

Contact Info

Product

Resources

About